Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.15B | -47.30M | -41.59M | -39.26M | -42.24M |
| Total Depreciation and Amortization | 944.80K | 840.60K | 506.80K | 912.30K | 975.80K |
| Total Amortization of Deferred Charges | -- | -- | 2.36M | -- | -- |
| Total Other Non-Cash Items | 157.12M | 1.11M | -6.23M | -2.79M | 6.58M |
| Change in Net Operating Assets | -14.23M | -25.29M | 19.17M | -2.39M | 1.30M |
| Cash from Operations | 1.30B | -70.64M | -25.79M | -43.52M | -33.38M |
| Capital Expenditure | -977.00K | -910.40K | -168.10K | -37.10K | -735.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 3.33M | -- | -- | -- |
| Other Investing Activities | -238.49M | 75.81M | 21.71M | -895.13M | -3.66M |
| Cash from Investing | -239.46M | 78.24M | 21.54M | -895.16M | -4.39M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -4.43M | -4.34M | -4.59M | -4.18M | -3.82M |
| Issuance of Common Stock | 27.09M | 3.55M | 81.00K | 5.11M | 7.04B |
| Repurchase of Common Stock | -332.41M | -- | 0.00 | -270.80M | -81.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00K | -2.36M | -211.17M |
| Cash from Financing | -47.12M | -111.60K | -658.10K | -40.12M | 973.05M |
| Foreign Exchange rate Adjustments | -25.47M | -411.60K | 517.50K | -288.20K | 136.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -100.00 | -- |
| Net Change in Cash | 983.85M | 7.07M | -4.39M | -979.09M | 935.42M |